3D bioprinting of cardiac tissue: current challenges and perspectives

Demand for donor hearts has increased globally due to cardiovascular diseases. Recently, three-dimensional (3D) bioprinting technology has been aimed at creating clinically viable cardiac constructs for the management of myocardial infarction (MI) and associated complications. Advances in 3D bioprinting show promise in aiding cardiac tissue repair following injury/ infarction and offer an alternative to organ transplantation. This article summarizes the basic principles of 3D bioprinting and recent attempts at reconstructing functional adult native cardiac tissue with a focus on current challenges and prospective strategies. [GRAPHICS] .

Automated summary

Advanced three-dimensional bioprinting technology shows promise in aiding cardiac tissue repair and potentially offering an alternative to organ transplantation. Despite facing challenges, there is still hope for the future.